News Novo highlights key 'hypo' data from Tresiba at EASD Novo hopes data will justify higher price compared with rival.
News AZ talks up Bydureon data, GLP-1 and glucagon combo AstraZeneca is hoping new data showing its Bydureon diabetes drug cuts overall death risk could stave off competition from Novo Nordisk's potential next generation GLP-1 drug.
News Teva appoints Lundbeck's Kare Schultz as CEO Unlike AZ's Soriot, Schultz "couldn't refuse" top job at Teva.
News FDA grants fast review for Roche's haemophilia drug Emicizumab is firm's latest blockbuster hopeful
News Novo's semaglutide outperforms Lilly GLP-1 rival If approved semaglutide could become set the standard for GLP-1 therapy
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
